Page last updated: 2024-09-04

chs 828 and terbutaline

chs 828 has been researched along with terbutaline in 1 studies

Compound Research Comparison

Studies
(chs 828)
Trials
(chs 828)
Recent Studies (post-2010)
(chs 828)
Studies
(terbutaline)
Trials
(terbutaline)
Recent Studies (post-2010) (terbutaline)
210173,216844322

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alisi, MA; Aprile, S; Clemente, N; Colombo, G; Galli, U; Genazzani, AA; Grosa, G; Mattoteia, D; Polenzani, L; Scanziani, E; Terrazzino, S; Travelli, C; Tron, GC1

Other Studies

1 other study(ies) available for chs 828 and terbutaline

ArticleYear
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group.
    European journal of medicinal chemistry, 2019, Nov-01, Volume: 181

    Topics: Animals; Cell Line, Tumor; Click Chemistry; Cytokines; Enzyme Inhibitors; Humans; Mice; Neoplasms; Nicotinamide Phosphoribosyltransferase; Triazoles

2019